Cell therapy is not always useful for the treatment of some diseases. A study has now been published in relation to Crohn’s disease, a chronic bowel disease that manifestly reduces quality of life and even decreases life expectancy. In the study (JAMB 314; 252-253, 2015), no differences were found as regards improvement in the disease between the group treated with usual therapy and the group treated with cell therapy, i.e. stem cells (adult haematopoietic cells) from the patient himself.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.